Fourth, although we have confirmed the great potential of CNN1 in pan-cancer immunotherapy, both inhibition and overexpression of CNN1 were found to be relevant in different tumors; therefore, more research has to be done to implement the use or targeting of CNN1 in tumor immunotherapy. This evidence concerns the gene CNN1 and neoplasm.